One telltale sign is a white or gray film on your tongue
Retatrutide acts as a triple incretin receptor agonist, simultaneously activating three distinct receptors: GLP-1 receptors stimulating insulin secretion in a glucose-dependent manner, slowing gastric emptying, and reducing appetite GIP receptors enhancing insulin release and potentially improving fat metabolism Glucagon receptors increasing energy expenditure and promoting fat breakdown in the liver This multi-receptor activity produces pronounced effects on body weight, blood glucose, lipid metabolism, and hepatic fat
Wegovy may cause serious side effects, including: Inflammation of your pancreas (pancreatitis)
Metformin Metformin remains the foundational therapy for type 2 diabetes because of its long-standing efficacy, low cost, and extensive clinical history
Tirzepatide is currently the only widely available medication that activates both pathways simultaneously
This happens either because the pancreas does not produce enough insulin or because the body cannot use insulin effectively